Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Accenture
Cerilliant
Deloitte
Teva
Boehringer Ingelheim
Dow
Moodys
Cipla

Generated: December 10, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018154

« Back to Dashboard

NDA 018154 describes LONITEN, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the LONITEN profile page.

The generic ingredient in LONITEN is minoxidil. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 018154
Tradename:LONITEN
Applicant:Pharmacia And Upjohn
Ingredient:minoxidil
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018154

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 018154

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn LONITEN minoxidil TABLET;ORAL 018154-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Citi
Accenture
US Army
Baxter
Farmers Insurance
McKinsey
Cerilliant
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.